Lisata Therapeutics, Inc. logo

Lisata Therapeutics, Inc. (LSTA) Q1 2026 Annual Earnings

LSTA·Reported May 11, 2026·After market close

Diluted EPS came in at $-0.50 (+9.1% YoY).

Diluted EPS
$-0.50
SEC

SEC Filings

Earnings release8-K not filed yet
Annual report10-K/A · 0000320017-26-000028

Financial Snapshot

Trailing eight quarters through Q1 2026

View all metrics

Q1 2026 Earnings FAQ

Common questions about Lisata Therapeutics, Inc.'s Q1 2026 earnings report.

Lisata Therapeutics, Inc. (LSTA) reported Q1 2026 earnings on May 11, 2026 after market close.

Lisata Therapeutics, Inc. reported diluted EPS of $-0.50 for Q1 2026.

Compared to the same quarter a year prior, diluted EPS grew 9.1% from $-0.55.

You can read the 10-K/A periodic report (0000320017-26-000028) directly on SEC EDGAR. The filing index links above go to sec.gov.